IssuerAnnouncementDetailsV2Portlet
Actions
Saudi Pharmaceutical Industries and Medical Appliances Corp. announces the appointment of a Chief Executive Officer
| Element List | Explanation |
|---|---|
| Introduction | In reference to the announcement of Saudi Pharmaceutical Industries and Medical Appliances Corporation (“SPIMACO") issued on 16/03/1445H, corresponding to 01/10/2023G, regarding the appointment of Mr. Jerome Cabannes as acting CEO, SPIMACO announces that its Board of Directors issued a resolution on 10/08/1445H, corresponding to 20/02/2024G, to appoint Mr. Jerome Cabannes as the Company’s Chief Executive Officer effective from 10/08/1445H (20/02/2024G). |
| Element List | Explanation |
|---|---|
| Appointment Type | Appointment |
| Name of the Appointed Person | Mr. Jerome Cabannes |
| Date of Board Resolution | 2024-02-20 Corresponding to 1445-08-10 |
| Date Work Commencement | 2024-02-20 Corresponding to 1445-08-10 |
| Brief Resume | Mr. Jerome Cabannes holds a master’s degree in biomedical engineering from Paul Sabatier University, France. He also holds multiple certifications in Business Strategy & M&A from Oxford University and Cambridge Universities, UK. With over 30 years of professional experience in the pharmaceutical & healthcare industry, Mr. Jerome has held leadership positions in various geographies at Servier Group, BIOGARAN, Stago Group, France, and AJ Group before joining SPIMACO. |
| Attached Documents |  |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 24.86
Net Change 0.38 (+1.55%)
Value Traded (Sar) 5,759,867.02
Volume Traded 233,590
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
- ${title}${badge}